Evidence map›Paper›PMID 32170806›Full record

ReviewLiver international : official journal of the International Association for the Study of the Liver2020

Liver injury during highly pathogenic human coronavirus infections.

Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng

3 registry-linked trialsAbstract readReview
In one paragraph

Review in Liver international : official journal of the International Association for the Study of the Liver, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 472 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
472citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04329559 completednot on this map

Clinical Characteristics of COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study

Typeobservational_patient_registrySponsorHepatopancreatobiliary Surgery Institute of Gansu ProvinceRan2020 to 2021Enrolled21ConditionsCOVID-19, Liver Cirrhosis
NCT04369807 completednot on this map

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

TypeobservationalSponsorPerspectumRan2020 to 2022Enrolled693ConditionsCOVID-19ArmsOutpatient MRI
NCT04375670 completednot on this map

COVID19-FOIE National Observatory. An Ambispective Cohort Study of All Consecutive Patients

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2020 to 2022Enrolled1,132ConditionsLiver Diseases, COVID19
3 · Its place in the literature

Who cites it

472 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. Review
  10. COVID-19 Infection, Drugs, and Liver Injury.Journal of clinical medicine · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

412 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Ling XuDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jia LiuDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Mengji LuJoint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
Dongliang YangDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xin ZhengDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0001-6564-7807

Funding

Fundamental Research Funds for the Central Universities 2020kfyXGYJ016Fundamental Research Funds for the Central Universities 2020kfyXGYJ028
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), the pathogen of 2019 novel coronavirus disease (COVID-19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS-CoV-2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS-CoV-2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases. Similarly, previous studies have shown that liver damage was common in the patients infected by the other two highly pathogenic coronavirus - severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), and associated with the severity of diseases. In this review, the characteristics and mechanism of liver injury caused by SARS-CoV, MERS-CoV as well as SARS-CoV-2 infection were summarized, which may provide help for further studies on the liver injury of COVID-19.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19Disease ProgressionHumansLiverMiddle East Respiratory Syndrome CoronavirusPandemicsPneumonia, ViralSARS-CoV-2Severe acute respiratory syndrome-related coronavirusCOVID-19liver injuryMERSSARSSARS-CoV-2

Identifiers

PMID32170806
PMCPMC7228361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.